James S. Scibetta

Insider Reports History

Entity
Individual
Location
C/O Bioenvision, Inc., 345 Park Avenue, 41 St. Floor, New York, NY
Signature
/s/ Keith A. Kucinski, attorney-in fact for James S. Scibetta
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James S. Scibetta:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aquestive Therapeutics, Inc. Director Common Stock 31.6K $25.6K $0.81 Jun 15, 2021 Direct
Matinas BioPharma Holdings, Inc. Director Stock option (right to buy) 437K Nov 1, 2023 Direct
Aquestive Therapeutics, Inc. Director Stock Option (Right to Purchase) 20K Jun 15, 2021 Direct

Insider Reports Filed by James S. Scibetta

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MTNB Matinas BioPharma Holdings, Inc. Nov 1, 2023 1 $0 4 Nov 3, 2023 Director
MTNB Matinas BioPharma Holdings, Inc. Nov 14, 2022 1 $0 4 Nov 16, 2022 Director
MTNB Matinas BioPharma Holdings, Inc. Nov 1, 2021 1 $0 4 Nov 2, 2021 Director
MTNB Matinas BioPharma Holdings, Inc. Jun 19, 2021 3 $0 4 Jun 24, 2021 Director
AQST Aquestive Therapeutics, Inc. Jun 15, 2021 1 $0 4 Jun 17, 2021 Director